Retraction
Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL-mediated apoptosis
Paper Information
Record ID:
43233
Author(s):
Journal:
Publication Date:
December 28, 2010
Retraction Date:
March 10, 2023
(2.7 years years ago)
Subjects:
Country:
🇯🇵 JapanArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/or.2023.8519Additional Notes:
see also: https://pubpeer.com/publications/FE2615E67A53CFC729C77AE8FB5A2B; Masayasu Iwase has institutional finding of misconduct;
Citations (13)
13
Total Citations1
Post-Retraction(7.7%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
20
Days since retraction (latest)
Paper citing Proteasome inhibitor sensitizes oral squamous cell...
Unknown Authors
Unknown Journal
Published: Unknown
Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
Zheng Zheng, Xiang Wang, Donglei Chen
Experimental and Therapeutic Medicine
Open Access
Published: Mar 2023
8 citations
8 citations
20 days after retraction
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro et al. (12 authors)
Pharmacology & Therapeutics
Open Access
Published: May 2020
92 citations
92 citations
1025 days before retraction
Co-expression analysis reveals key gene modules and pathways of oral squamous cell carcinoma
Xiao Li, Weiwei Hu, Li Wang et al. (4 authors)
Cancer Biomarkers
Published: Jun 2018
2 citations
2 citations
1729 days before retraction
MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer
Weijiang Zhang, Jianwei Zhou, Xiaoqing Zhu et al. (4 authors)
Gene
Published: Jun 2017
29 citations
29 citations
2080 days before retraction
MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4
Changlong Xu, Liang Shi, Weilai Chen et al. (8 authors)
Oncotarget
Open Access
Published: Mar 2017
23 citations
23 citations
2171 days before retraction
Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism
Jessica Bullenkamp, Nina Raulf, Bushra Ayaz et al. (8 authors)
Cell Death and Disease
Open Access
Published: Oct 2014
30 citations
30 citations
3060 days before retraction
The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors
Daniel E. Johnson
Endocrine Related Cancer
Open Access
Published: Mar 2014
91 citations
91 citations
3276 days before retraction
Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches
Jason Kass, Jennifer R. Grandis, Daniel E. Johnson
Resistance to targeted anti-cancer therapeutics
Published: Jan 2014
3355 days before retraction
FLIP: Molecular switch between apoptosis and necroptosis
Jingjing Gong, Saikartik A. Kumar, Gilian Graham et al. (4 authors)
Molecular Carcinogenesis
Published: Apr 2013
21 citations
21 citations
3605 days before retraction
TRAIL induces apoptosis in oral squamous carcinoma cells: a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5
Junjie Chen, Constantinos M. Mikelis, Yaqin Zhang et al. (5 authors)
Oncotarget
Open Access
Published: Feb 2013
29 citations
29 citations
3667 days before retraction
TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis
Syam Prakash Somasekharan, Michal Koc, Alexandre Morizot et al. (8 authors)
APOPTOSIS
Open Access
Published: Nov 2012
27 citations
27 citations
3761 days before retraction
The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells
Eun-Sil Sung, Kyung-Jin Park, Hye‐Ji Choi et al. (5 authors)
Experimental Cell Research
Published: Apr 2012
21 citations
21 citations
3986 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025